Welcome to our dedicated page for Amdocs SEC filings (Ticker: DOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amdocs Limited SEC filings document the disclosures of a foreign private issuer that provides software and services to communications and media companies. Its Form 6-K reports include quarterly and annual financial materials, consolidated financial statements, operating and financial review, earnings presentations, and disclosures on equity activity and issuer purchases.
The filing record also covers shareholder meeting materials and voting results, including board elections, employee share purchase plan amendments, dividend program approvals, auditor ratification, and governance changes involving executive leadership and board composition. Registration-statement incorporation language connects selected Form 6-K reports to Amdocs' equity compensation filings on Form S-8.
DOX filed a Form 144 notifying a proposed sale of Ordinary shares tied to previously issued Restricted Stock Units. The filing lists multiple award dates and grant sizes, including 41,434 (11/13/2018), 30,895 (11/15/2019), and 18,724 (11/15/2019).
The notice identifies Oppenheimer & Co. Inc. as the broker and references 03/18/2026 and Nasdaq as the market; the filing lists several additional RSU grant counts by grant date.
Amdocs Ltd director Yvette Kanouff filed an initial insider ownership report showing beneficial ownership of 24,200 Ordinary Shares of the company. These holdings are reported as being owned directly and include Ordinary Shares subject to outstanding restricted stock awards. The filing does not report any recent buy or sell transactions, only the current equity position.
Amdocs Ltd officer Rapaport-Dagim Tamar filed an initial ownership report showing 294,517 Ordinary Shares held directly. This total includes Ordinary Shares that are subject to outstanding restricted stock awards, reflecting both vested and unvested equity-based compensation, with no new buy or sell transaction reported.
Amdocs Ltd director Rafael De La Vega has filed an initial ownership report showing his equity stake in the company. The Form 3 states that he directly holds 29,836 Ordinary Shares, and a footnote explains this number includes Ordinary Shares subject to outstanding restricted stock awards. The filing does not report any recent share purchases or sales; it simply establishes his current holdings as a company director.
Amdocs Ltd director Adrian Gardner has reported his share ownership in the company. He holds 33,522 Ordinary Shares directly and an additional 20,000 Ordinary Shares indirectly through his spouse. The reported amounts include Ordinary Shares that are subject to outstanding restricted stock awards.
AMDOCS LTD director Genish Amos filed an initial ownership report showing his equity position in the company. The filing reports direct ownership of 11,353 Ordinary Shares, including shares subject to outstanding restricted stock units. This Form 3 does not disclose any buy or sell transactions; it simply establishes his current holdings.
Amdocs Ltd director Gelman Eliahu Meir filed an initial ownership report showing a substantial equity stake in the company. The Form 3 lists direct beneficial ownership of 340,136 Ordinary Shares. A footnote explains that this figure includes Ordinary Shares subject to outstanding restricted stock awards, so the total reflects both vested and unvested equity-based compensation rather than a recent market transaction.
Amdocs Ltd director Veronique Morali reported her initial holdings of company equity in a Form 3. The filing shows she beneficially owns 4,405 Ordinary Shares, which are represented by shares of Class A Common Stock subject to outstanding restricted stock units. This reflects her existing equity-based compensation position rather than a new market transaction.
Amdocs Ltd director John Anthony MacDonald filed an initial ownership report showing direct beneficial ownership of 24,189 Ordinary Shares. This total includes Ordinary Shares subject to outstanding restricted stock units, reflecting both currently held shares and equity awards that may vest in the future.
Amdocs Ltd officer Matthew E. Smith filed an initial ownership report showing a mix of stock options and ordinary shares. He holds options over 2,683 Ordinary Shares at an exercise price of 55.8800 expiring on February 1, 2029, 3,127 shares at 71.9500 expiring on February 1, 2030, and 925 shares at 67.4600 expiring on June 1, 2028. The filing also lists 2,014 Ordinary Shares held directly, including shares subject to outstanding restricted stock awards. The options vest in equal annual installments over four years from their grant dates.